Diacylglycerol kinase ζ limits the generation of natural regulatory T cells

Science Signaling

Volumn 6, Issue 303, 2013, Pages

  Schmidt, Amanda M ^a   Zou, Tao ^a   Joshi, Rohan P ^b   Leichner, Theresa M ^a   Pimentel, Matthew A ^b   Sommers, Connie L ^c   Kambayashi, Taku ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; DIACYLGLYCEROL KINASE; DIACYLGLYCEROL KINASE ZETA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 2 RECEPTOR ALPHA; MITOGEN ACTIVATED PROTEIN KINASE; T LYMPHOCYTE RECEPTOR; TRANSCRIPTION FACTOR FOXP3; TRANSCRIPTION FACTOR REL; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CD4+ CD25+ T LYMPHOCYTE; CELL MATURATION; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; IMMUNOLOGICAL TOLERANCE; IN VITRO STUDY; INTRACELLULAR SIGNALING; MOUSE; NONHUMAN; PRE T LYMPHOCYTE; PRIORITY JOURNAL; PROTEIN DEPLETION; REGULATORY T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; THYMOCYTE; WILD TYPE;

ANIMALS; ANTIGENS, CD4; BLOTTING, WESTERN; CELL DIFFERENTIATION; DIACYLGLYCEROL KINASE; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; FLOW CYTOMETRY; FORKHEAD TRANSCRIPTION FACTORS; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-REL; RECEPTORS, ANTIGEN, T-CELL; SIGNAL TRANSDUCTION; T-LYMPHOCYTES, REGULATORY; THYMUS GLAND;

EID: 84889263101     PISSN: 19450877     EISSN: 19379145     Source Type: Journal    
DOI: 10.1126/scisignal.2004411     Document Type: Article

References (68)

1. S. Z. Josefowicz, L. F. Lu, A. Y. Rudensky, Regulatory T cells: Mechanisms of differentiation and function. Annu. Rev. Immunol. 30, 531-564 (2012).
2. S. Sakaguchi, T. Yamaguchi, T. Nomura, M. Ono, Regulatory T cells and immune tolerance. Cell 133, 775-787 (2008).
3. C. L. Bennett, J. Christie, F. Ramsdell, M. E. Brunkow, P. J. Ferguson, L. Whitesell, T. E. Kelly, F. T. Saulsbury, P. F. Chance, H. D. Ochs, The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3. Nat. Genet. 27, 20-21 (2001).
4. M. E. Brunkow, E. W. Jeffery, K. A. Hjerrild, B. Paeper, L. B. Clark, S. A. Yasayko, J. E. Wilkinson, D. Galas, S. F. Ziegler, F. Ramsdell, Disruption of a new forkhead/winged-helix protein, scurfin, results in the fatal lymphoproliferative disorder of the scurfy mouse. Nat. Genet. 27, 68-73 (2001).
5. J. M. Kim, J. P. Rasmussen, A. Y. Rudensky, Regulatory T cells prevent catastrophic autoimmunity throughout the lifespan of mice. Nat. Immunol. 8, 191-197 (2007).
6. + regulatory T cells induces a scurfy-like disease. J. Exp. Med. 204, 57-63 (2007).
7. S. Sakaguchi, N. Sakaguchi, M. Asano, M. Itoh, M. Toda, Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. Int. J. Immunol. 155, 1151-1164 (1995).
8. H. Y. Wang, R. F. Wang, Regulatory T cells and cancer. Curr. Opin. Immunol. 19, 217-223 (2007).
9. Y. Belkaid, B. T. Rouse, Natural regulatory T cells in infectious disease. Nat. Immunol. 6, 353-360 (2005).
10. + regulatory T cells, immune stimulation and host defence against infection. Immunology 136, 1-10 (2012).
11. A. Cebula, M. Seweryn, G. A. Rempala, S. S. Pabla, R. A. McIndoe, T. L. Denning, L. Bry, P. Kraj, P. Kisielow, L. Ignatowicz, Thymus-derived regulatory T cells contribute to tolerance to commensal microbiota. Nature 497, 258-262 (2013).
12. B. Singh, S. Read, C. Asseman, V. Malmström, C. Mottet, L. A. Stephens, R. Stepankova, H. Tlaskalova, F. Powrie, Control of intestinal inflammation by regulatory T cells. Immunol. Rev. 182, 190-200 (2001).
13. + regulatory T cells in immune tolerance. Annu. Rev. Immunol. 30, 733-758 (2012).
14. C. W. Lio, C. S. Hsieh, Becoming self-aware: The thymic education of regulatory T cells. Curr. Opin. Immunol. 23, 213-219 (2011).
15. A. E. Moran, K. A. Hogquist, T-cell receptor affinity in thymic development. Immunology 135, 261-267 (2012).
16. I. Apostolou, A. Sarukhan, L. Klein, H. von Boehmer, Origin of regulatory T cells with known specificity for antigen. Nat. Immunol. 3, 756-763 (2002).
17. B. Knoechel, J. Lohr, E. Kahn, J. A. Bluestone, A. K. Abbas, Sequential development of interleukin 2-dependent effector and regulatory T cells in response to endogenous systemic antigen. J. Exp. Med. 202, 1375-1386 (2005).
18. + regulatory T cells in vivo. J. Exp. Med. 198, 249-258 (2003).
19. + regulatory T cells induced by an agonist self-peptide. Nat. Immunol. 2, 301-306 (2001).
20. + regulatory T cells from autoreactive T cells simultaneously with their negative selection in the thymus and from nonautoreactive T cells by endogenous TCR expression. J. Immunol. 168, 4399-4405 (2002).
21. H. M. Lee, J. L. Bautista, J. Scott-Browne, J. F. Mohan, C. S. Hsieh, A broad range of self-reactivity drives thymic regulatory T cell selection to limit responses to self. Immunity 37, 475-486 (2012).
22. L. P. Kane, J. Lin, A. Weiss, Signal transduction by the TCR for antigen. Curr. Opin. Immunol. 12, 242-249 (2000).
23. J. E. Smith-Garvin, G. A. Koretzky, M. S. Jordan, T cell activation. Annu. Rev. Immunol. 27, 591-619 (2009).
24. X. P. Zhong, E. A. Hainey, B. A. Olenchock, M. S. Jordan, J. S. Maltzman, K. E. Nichols, H. Shen, G. A. Koretzky, Enhanced T cell responses due to diacylglycerol kinase ζ deficiency. Nat. Immunol. 4, 882-890 (2003).
25. X. P. Zhong, E. A. Hainey, B. A. Olenchock, H. Zhao, M. K. Topham, G. A. Koretzky, Regulation of T cell receptor-induced activation of the Ras-ERK pathway by diacylglycerol kinase ζ. J. Biol. Chem. 277, 31089-31098 (2002).
26. B. A. Olenchock, R. Guo, J. H. Carpenter, M. Jordan, M. K. Topham, G. A. Koretzky, X. P. Zhong, Disruption of diacylglycerol metabolism impairs the induction of T cell anergy. Nat. Immunol. 7, 1174-1181 (2006).
27. R. P. Joshi, A. M. Schmidt, J. Das, D. Pytel, M. J. Riese, M. Lester, J. A. Diehl, E. M. Behrens, T. Kambayashi, G. A. Koretzky, The ζ isoform of diacylglycerol kinase plays a predominant role in regulatory T cell development and TCR-mediated Ras signaling. Sci. Signal. 6, ra102 (2013).
28. A. E. Moran, K. L. Holzapfel, Y. Xing, N. R. Cunningham, J. S. Maltzman, J. Punt, K. A. Hogquist, T cell receptor signal strength in Treg and iNKT cell development demonstrated by a novel fluorescent reporter mouse. J. Exp. Med. 208, 1279-1289 (2011).
29. B. A. Osborne, S. W. Smith, Z. G. Liu, K. A. McLaughlin, L. Grimm, L. M. Schwartz, Identification of genes induced during apoptosis in T lymphocytes. Immunol. Rev. 142, 301-320 (1994).
30. T. A. Baldwin, K. A. Hogquist, Transcriptional analysis of clonal deletion in vivo. J. Immunol. 179, 837-844 (2007).
31. C. W. Lio, C. S. Hsieh, A two-step process for thymic regulatory T cell development. Immunity 28, 100-111 (2008).
32. H. Kishimoto, J. Sprent, Negative selection in the thymus includes semimature T cells. J. Exp. Med. 185, 263-271 (1997).
33. M. A. Burchill, J. Yang, K. B. Vang, M. A. Farrar, Interleukin-2 receptor signaling in regulatory T cell development and homeostasis. Immunol. Lett. 114, 1-8 (2007).
34. G. Wirnsberger, F. Mair, L. Klein, Regulatory T cell differentiation of thymocytes does not require a dedicated antigen-presenting cell but is under T cell-intrinsic developmental control. Proc. Natl. Acad. Sci. U.S.A. 106, 10278-10283 (2009).
35. K. B. Vang, J. Yang, A. J. Pagan, L. X. Li, J. Wang, J. M. Green, A. A. Beg, M. A. Farrar, Cutting edge: CD28 and c-Rel-dependent pathways initiate regulatory T cell development. J. Immunol. 184, 4074-4077 (2010).
36. M. A. Burchill, J. Yang, K. B. Vang, J. J. Moon, H. H. Chu, C. W. Lio, A. L. Vegoe, C. S. Hsieh, M. K. Jenkins, M. A. Farrar, Linked T cell receptor and cytokine signaling govern the development of the regulatory T cell repertoire. Immunity 28, 112-121 (2008).
37. X. Tai, M. Cowan, L. Feigenbaum, A. Singer, CD28 costimulation of developing thymocytes induces Foxp3 expression and regulatory T cell differentiation independently of interleukin 2. Nat. Immunol. 6, 152-162 (2005).
38. L. Tuosto, NF-κB family of transcription factors: Biochemical players of CD28 co-stimulation. Immunol. Lett. 135, 1-9 (2011).
39. E. K. Deenick, A. R. Elford, M. Pellegrini, H. Hall, T. W. Mak, P. S. Ohashi, c-Rel but not NF-κB1 is important for T regulatory cell development. Eur. J. Immunol. 40, 677-681 (2010).
40. + CD4 regulatory T cells. PLoS One 6, e26851 (2011).
41. + CD4 regulatory T cells. J. Exp. Med. 206, 3001-3014 (2009).
42. M. Long, S. G. Park, I. Strickland, M. S. Hayden, S. Ghosh, Nuclear factor-κB modulates regulatory T cell development by directly regulating expression of Foxp3 transcription factor. Immunity 31, 921-931 (2009).
43. + regulatory t cells is driven by the c-Rel enhanceosome. Immunity 31, 932-940 (2009).
44. Y. Zheng, S. Josefowicz, A. Chaudhry, X. P. Peng, K. Forbush, A. Y. Rudensky, Role of conserved non-coding DNA elements in the Foxp3 gene in regulatory T-cell fate. Nature 463, 808-812 (2010).
45. J. Cheng, A. Montecalvo, L. P. Kane, Regulation of NF-κB induction by TCR/CD28. Immunol. Res. 50, 113-117 (2011).
46. N. Brose, C. Rosenmund, Move over protein kinase C, you've got company: Alternative cellular effectors of diacylglycerol and phorbol esters. J. Cell Sci. 115, 4399-4411 (2002).
47. M. F. Favata, K. Y. Horiuchi, E. J. Manos, A. J. Daulerio, D. A. Stradley, W. S. Feeser, D. E. Van Dyk, W. J. Pitts, R. A. Earl, F. Hobbs, R. A. Copeland, R. L. Magolda, P. A. Scherle, J. M. Trzaskos, Identification of a novel inhibitor of mitogen-activated protein kinase kinase. J. Biol. Chem. 273, 18623-18632 (1998).
48. T. R. Malek, I. Castro, Interleukin-2 receptor signaling: At the interface between tolerance and immunity. Immunity 33, 153-165 (2010).
49. L. L. Sharp, D. A. Schwarz, C. M. Bott, C. J. Marshall, S. M. Hedrick, The influence of the MAPK pathway on T cell lineage commitment. Immunity 7, 609-618 (1997).
50. J. D. Fontenot, J. L. Dooley, A. G. Farr, A. Y. Rudensky, Developmental regulation of Foxp3 expression during ontogeny. J. Exp. Med. 202, 901-906 (2005).
51. H. P. Kim, W. J. Leonard, The basis for TCR-mediated regulation of the IL-2 receptor α chain gene: Role of widely separated regulatory elements. EMBO J. 21, 3051-3059 (2002).
52. T. H. Tan, G. P. Huang, A. Sica, P. Ghosh, H. A. Young, D. L. Longo, N. R. Rice, κB site-dependent activation of the interleukin-2 receptor α-chain gene promoter by human c-Rel. Mol. Cell. Biol. 12, 4067-4075 (1992).
53. H. P. Kim, J. Imbert, W. J. Leonard, Both integrated and differential regulation of components of the IL-2/IL-2 receptor system. Cytokine Growth Factor Rev. 17, 349-366 (2006).
54. S. John, R. B. Reeves, J. X. Lin, R. Child, J. M. Leiden, C. B. Thompson, W. J. Leonard, Regulation of cell-type-specific interleukin-2 receptor α-chain gene expression: Potential role of physical interactions between Elf-1, HMG-I(Y), and NF-κB family proteins. Mol. Cell. Biol. 15, 1786-1796 (1995).
55. P. Y. Mantel, N. Ouaked, B. Rückert, C. Karagiannidis, R. Welz, K. Blaser, C. B. Schmidt-Weber, Molecular mechanisms underlying FOXP3 induction in human T cells. J. Immunol. 176, 3593-3602 (2006).
56. M. Yoshimi, S. Goyama, M. Kawazu, M. Nakagawa, M. Ichikawa, Y. Imai, K. Kumano, T. Asai, J. C. Mulloy, A. S. Kraft, T. Takahashi, N. Shirafuji, M. Kurokawa, Multiple phosphorylation sites are important for RUNX1 activity in early hematopoiesis and T-cell differentiation. Eur. J. Immunol. 42, 1044-1050 (2012).
57. T. Tanaka, M. Kurokawa, K. Ueki, K. Tanaka, Y. Imai, K. Mitani, K. Okazaki, N. Sagata, Y. Yazaki, Y. Shibata, T. Kadowaki, H. Hirai, The extracellular signal-regulated kinase pathway phosphorylates AML1, an acute myeloid leukemia gene product, and potentially regulates its transactivation ability. Mol. Cell. Biol. 16, 3967-3979 (1996).
58. M. Ono, H. Yaguchi, N. Ohkura, I. Kitabayashi, Y. Nagamura, T. Nomura, Y. Miyachi, T. Tsukada, S. Sakaguchi, Foxp3 controls regulatory T-cell function by interacting with AML1/Runx1. Nature 446, 685-689 (2007).
59. D. Rudra, T. Egawa, M. M. Chong, P. Treuting, D. R. Littman, A. Y. Rudensky, Runx-CBFβ complexes control expression of the transcription factor Foxp3 in regulatory T cells. Nat. Immunol. 10, 1170-1177 (2009).
60. B. K. Gorentla, C. K. Wan, X. P. Zhong, Negative regulation of mTOR activation by diacylglycerol kinases. Blood 117, 4022-4031 (2011).
61. S. Sauer, L. Bruno, A. Hertweck, D. Finlay, M. Leleu, M. Spivakov, Z. A. Knight, B. S. Cobb, D. Cantrell, E. O'Connor, K. M. Shokat, A. G. Fisher, M. Merkenschlager, T cell receptor signaling controls Foxp3 expression via PI3K, Akt, and mTOR. Proc. Natl. Acad. Sci. U.S.A. 105, 7797-7802 (2008).
62. + cells. J. Exp. Med. 205, 565-574 (2008).
63. X. P. Zhong, R. Guo, H. Zhou, C. Liu, C. K. Wan, Diacylglycerol kinases in immune cell function and self-tolerance. Immunol. Rev. 224, 249-264 (2008).
64. vav associates with tyrosine-phosphorylated SLP-76 in antigen-stimulated T cells. J. Exp. Med. 184, 1161-1166 (1996).
65. T. Yokosuka, W. Kobayashi, K. Sakata-Sogawa, M. Takamatsu, A. Hashimoto-Tane, M. L. Dustin, M. Tokunaga, T. Saito, Spatiotemporal regulation of T cell costimulation by TCR-CD28 microclusters and protein kinase C θ translocation. Immunity 29, 589-601 (2008).
66. E. Díaz-Flores, M. Siliceo, A. C. Martínez, I. Mérida, Membrane translocation of protein kinase Cθ during T lymphocyte activation requires phospholipase C-γ-generated diacylglycerol. J. Biol. Chem. 278, 29208-29215 (2003).
67. H. C. Liou, Z. Jin, J. Tumang, S. Andjelic, K. A. Smith, M. L. Liou, c-Rel is crucial for lymphocyte proliferation but dispensable for T cell effector function. Int. Immunol. 11, 361-371 (1999).
68. T. Kambayashi, M. Okumura, R. G. Baker, C. J. Hsu, T. Baumgart, W. Zhang, G. A. Koretzky, Independent and cooperative roles of adaptor molecules in proximal signaling during FcεRI-mediated mast cell activation. Mol. Cell. Biol. 30, 4188-4196 (2010).